Setting

Asia Pacific Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Country: Trend Forecast and Growth Opportunity

Published: 30 Jan 2022 | Report Code: 10248357 | Pages: 110

Asia Pacific blood culture tests market will grow by 9.7% annually with a total addressable market cap of $16.74 billion over 2022-2031 owing to the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic. Highlighted with 32 tables and 54 figures, this 110-page report “Asia Pacific Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables o Blood Culture Media o Assay Kits & Reagents o Blood Culture Accessories • Instruments o Automated Blood Culture Systems o Supporting Laboratory Equipment • Software and Services Based on Method, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Conventional/Manual Methods • Automated Methods Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Culture-Based Technologies • Molecular Technologies o Microarrays o Polymerase Chain Reaction (PCR) o PNA-FISH • Proteomics Technology • Other Technologies Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Bacteremia • Fungemia • Mycobacterial Detection Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospital Laboratories • Reference Laboratories • Academic Research Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Autobio Diagnostics Co., Ltd. Becton, Dickinson and Company (BD) Binder Gmbh Biobase Biotech (Jinan) Co., Ltd. BioMérieux SA Bruker Corporation Carl Zeiss Ag Cepheid Inc. (Danaher Corporation) F. Hoffmann-La Roche Ltd. Luminex Corporation Neogen Corporation (Abtek Biologicals) OpGen Inc. T2 Biosystems, Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	22
2.2 Major Growth Drivers	24
2.3 Market Restraints and Challenges	29
2.4 Emerging Opportunities and Market Trends	32
2.5 Porter’s Fiver Forces Analysis	36
3 Segmentation of Asia Pacific Market by Product	40
3.1 Market Overview by Product	40
3.2 Consumables	42
3.2.1 Blood Culture Media	44
3.2.2 Assay Kits & Reagents	45
3.2.3 Blood Culture Accessories	46
3.3 Instruments	47
3.3.1 Automated Blood Culture Systems	48
3.3.2 Supporting Laboratory Equipment	49
3.4 Software and Services	50
4 Segmentation of Asia Pacific Market by Method	51
4.1 Market Overview by Method	51
4.2 Conventional/Manual Methods	53
4.3 Automated Methods	54
5 Segmentation of Asia Pacific Market by Technology	55
5.1 Market Overview by Technology	55
5.2 Culture-Based Technologies	57
5.3 Molecular Technologies	58
5.3.1 Microarrays	59
5.3.2 Polymerase Chain Reaction (PCR)	60
5.3.3 PNA-FISH	61
5.4 Proteomics Technology	62
5.5 Other Technologies	63
6 Segmentation of Asia Pacific Market by Application	64
6.1 Market Overview by Application	64
6.2 Bacteremia	66
6.3 Fungemia	67
6.4 Mycobacterial Detection	68
7 Segmentation of Asia Pacific Market by End User	69
7.1 Market Overview by End User	69
7.2 Hospital Laboratories	71
7.3 Reference Laboratories	72
7.4 Academic Research Laboratories	73
7.5 Other End Users	74
8 Asia-Pacific Market 2021-2031 by Country	75
8.1 Overview of Asia-Pacific Market	75
8.2 Japan	78
8.3 China	81
8.4 Australia	83
8.5 India	85
8.6 South Korea	87
8.7 Rest of APAC Region	89
9 Competitive Landscape	91
9.1 Overview of Key Vendors	91
9.2 New Product Launch, Partnership, Investment, and M&A	94
9.3 Company Profiles	95
Autobio Diagnostics Co., Ltd.	95
Becton, Dickinson and Company (BD)	97
Binder Gmbh	98
Biobase Biotech (Jinan) Co., Ltd.	99
BioMérieux SA	100
Bruker Corporation	101
Carl Zeiss Ag	102
Cepheid Inc. (Danaher Corporation)	103
F. Hoffmann-La Roche Ltd.	104
Luminex Corporation	105
Neogen Corporation (Abtek Biologicals)	106
OpGen Inc.	107
T2 Biosystems, Inc.	108
Thermo Fisher Scientific Inc.	109
RELATED REPORTS	110

List Of Tables:


Table 1.  Snapshot of Asia Pacific Blood Culture Tests Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Health Spending by Region, $ bn, 2013-2020	28
Table 4.  Main Product Trends and Market Opportunities in Asia Pacific Blood Culture Tests Market	32
Table 5. Asia Pacific Blood Culture Tests Market by Product, 2021-2031, $ mn	40
Table 6. Asia Pacific Blood Culture Tests Market: Consumables by Type, 2021-2031, $ mn	42
Table 7. Asia Pacific Blood Culture Tests Market: Instruments by Type, 2021-2031, $ mn	47
Table 8. Asia Pacific Blood Culture Tests Market by Method, 2021-2031, $ mn	51
Table 9. Asia Pacific Blood Culture Tests Market by Technology, 2021-2031, $ mn	55
Table 10. Asia Pacific Blood Culture Tests Market: Molecular Technologies by Type, 2021-2031, $ mn	58
Table 11. Asia Pacific Blood Culture Tests Market by Application, 2021-2031, $ mn	64
Table 12. Asia Pacific Blood Culture Tests Market by End User, 2021-2031, $ mn	69
Table 13. APAC Blood Culture Tests Market by Country, 2021-2031, $ mn	76
Table 14. Japan Blood Culture Tests Market by Product, 2021-2031, $ mn	80
Table 15. Japan Blood Culture Tests Market by Application, 2021-2031, $ mn	80
Table 16. Japan Blood Culture Tests Market by End User, 2021-2031, $ mn	80
Table 17. China Blood Culture Tests Market by Product, 2021-2031, $ mn	82
Table 18. China Blood Culture Tests Market by Application, 2021-2031, $ mn	82
Table 19. China Blood Culture Tests Market by End User, 2021-2031, $ mn	82
Table 20. Australia Blood Culture Tests Market by Product, 2021-2031, $ mn	84
Table 21. Australia Blood Culture Tests Market by Application, 2021-2031, $ mn	84
Table 22. Australia Blood Culture Tests Market by End User, 2021-2031, $ mn	84
Table 23. India Blood Culture Tests Market by Product, 2021-2031, $ mn	86
Table 24. India Blood Culture Tests Market by Application, 2021-2031, $ mn	86
Table 25. India Blood Culture Tests Market by End User, 2021-2031, $ mn	86
Table 26. South Korea Blood Culture Tests Market by Product, 2021-2031, $ mn	88
Table 27. South Korea Blood Culture Tests Market by Application, 2021-2031, $ mn	88
Table 28. South Korea Blood Culture Tests Market by End User, 2021-2031, $ mn	88
Table 29. Blood Culture Tests Market in Rest of APAC by Country/Region, 2021-2031, $ mn	90
Table 30. Autobio Diagnostics Co., Ltd.: Company Snapshot	95
Table 31. Autobio Diagnostics Co., Ltd.: Business Segmentation	96
Table 32. Autobio Diagnostics Co., Ltd.: Product Portfolio	96

List Of Figures:


Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. Asia Pacific Blood Culture Tests Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Blood Culture Tests Market	24
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	27
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Blood Culture Tests Market	29
Figure 10. Investment Opportunity Analysis	33
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Blood Culture Tests Market	36
Figure 12. Breakdown of Asia Pacific Blood Culture Tests Market by Product, 2021-2031, % of Revenue	41
Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)	41
Figure 14. Asia Pacific Blood Culture Tests Market by Product: Consumables, 2021-2031, $ mn	42
Figure 15. Asia Pacific Blood Culture Tests Market by Consumables: Blood Culture Media, 2021-2031, $ mn	44
Figure 16. Asia Pacific Blood Culture Tests Market by Consumables: Assay Kits & Reagents, 2021-2031, $ mn	45
Figure 17. Asia Pacific Blood Culture Tests Market by Consumables: Blood Culture Accessories, 2021-2031, $ mn	46
Figure 18. Asia Pacific Blood Culture Tests Market by Product: Instruments, 2021-2031, $ mn	47
Figure 19. Asia Pacific Blood Culture Tests Market by Instruments: Automated Blood Culture Systems, 2021-2031, $ mn	48
Figure 20. Asia Pacific Blood Culture Tests Market by Instruments: Supporting Laboratory Equipment, 2021-2031, $ mn	49
Figure 21. Asia Pacific Blood Culture Tests Market by Product: Software and Services, 2021-2031, $ mn	50
Figure 22. Breakdown of Asia Pacific Blood Culture Tests Market by Method, 2021-2031, % of Sales Revenue	52
Figure 23. Asia Pacific Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%)	52
Figure 24. Asia Pacific Blood Culture Tests Market by Method: Conventional/Manual Methods, 2021-2031, $ mn	53
Figure 25. Asia Pacific Blood Culture Tests Market by Method: Automated Methods, 2021-2031, $ mn	54
Figure 26. Breakdown of Asia Pacific Blood Culture Tests Market by Technology, 2021-2031, % of Sales Revenue	56
Figure 27. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	56
Figure 28. Asia Pacific Blood Culture Tests Market by Technology: Culture-Based Technologies, 2021-2031, $ mn	57
Figure 29. Asia Pacific Blood Culture Tests Market by Technology: Molecular Technologies, 2021-2031, $ mn	58
Figure 30. Asia Pacific Blood Culture Tests Market by Molecular Technologies: Microarrays, 2021-2031, $ mn	59
Figure 31. Asia Pacific Blood Culture Tests Market by Molecular Technologies: Polymerase Chain Reaction (PCR), 2021-2031, $ mn	60
Figure 32. Asia Pacific Blood Culture Tests Market by Molecular Technologies: PNA-FISH, 2021-2031, $ mn	61
Figure 33. Asia Pacific Blood Culture Tests Market by Technology: Proteomics Technology, 2021-2031, $ mn	62
Figure 34. Asia Pacific Blood Culture Tests Market by Technology: Other Technologies, 2021-2031, $ mn	63
Figure 35. Breakdown of Asia Pacific Blood Culture Tests Market by Application, 2021-2031, % of Revenue	65
Figure 36. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	65
Figure 37. Asia Pacific Blood Culture Tests Market by Application: Bacteremia, 2021-2031, $ mn	66
Figure 38. Asia Pacific Blood Culture Tests Market by Application: Fungemia, 2021-2031, $ mn	67
Figure 39. Asia Pacific Blood Culture Tests Market by Application: Mycobacterial Detection, 2021-2031, $ mn	68
Figure 40. Breakdown of Asia Pacific Blood Culture Tests Market by End User, 2021-2031, % of Revenue	70
Figure 41. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	70
Figure 42. Asia Pacific Blood Culture Tests Market by End User: Hospital Laboratories, 2021-2031, $ mn	71
Figure 43. Asia Pacific Blood Culture Tests Market by End User: Reference Laboratories, 2021-2031, $ mn	72
Figure 44. Asia Pacific Blood Culture Tests Market by End User: Academic Research Laboratories, 2021-2031, $ mn	73
Figure 45. Asia Pacific Blood Culture Tests Market by End User: Other End Users, 2021-2031, $ mn	74
Figure 46. Breakdown of APAC Blood Culture Tests Market by Country, 2021 and 2031, % of Revenue	76
Figure 47. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	77
Figure 48.  Blood Culture Tests Market in Japan, 2021-2031, $ mn	79
Figure 49.  Blood Culture Tests Market in China, 2021-2031, $ mn	81
Figure 50.  Blood Culture Tests Market in Australia, 2021-2031, $ mn	83
Figure 51.  Blood Culture Tests Market in India, 2021-2031, $ mn	85
Figure 52.  Blood Culture Tests Market in South Korea, 2021-2031, $ mn	87
Figure 53.  Blood Culture Tests Market in Rest of APAC, 2021-2031, $ mn	89
Figure 54. Growth Stage of Asia Pacific Blood Culture Tests Industry over the Forecast Period	91
Key Players:
 
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioMérieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)